Skip to main content
Free EU delivery over €110.00Ships to all 27 EU + 3 EEA countriesSealed manufacturer packs · plain packagingNow accepting Credit & Debit cards
New: pay by Credit or Debit card — we email you a secure payment link.

Active ingredient

Carisoprodol

What is carisoprodol?

Carisoprodol is a centrally acting muscle relaxant that was used mainly for acute lower back pain. In 2007 the European Medicines Agency concluded that its risks of abuse, addiction, intoxication and impaired coordination outweigh its benefits, and recommended suspending every carisoprodol marketing authorisation in the EU; prescribers were told to stop issuing new prescriptions.

Reviewed by the Kam4eu editorial team on 13 August 2026 · Next review August 2027

Carisoprodol medicines we deliver

Browse the full Pain Relief range

4 generic Carisoprodol products — same molecule, different brands, formats and pack sizes.

What carisoprodol was authorised for

  • Pain, mainly acute (short-lived) lower back pain; it acts on nerve cells in the brain and spinal cord, helping muscles relax.
  • Before the 2007 review it was authorised in 12 European countries, alone or combined with paracetamol or other medicines, and available only on prescription.
  • The EMA concluded that alternative medicines for lower back pain seem as effective, with a better safety profile.

Source: EMA — Carisoprodol referral

Why the EMA recommended suspending carisoprodol

  • In March 2007 Norway's medicines authority concluded that the risks outweighed the benefits, after new information on abuse and addiction, intoxication and psychomotor impairment; the company agreed to withdraw it there.
  • The EMA's scientific committee (CHMP) then reviewed all available data and confirmed a risk of abuse and addiction, intoxication and psychomotor impairment.
  • It noted that blood levels of carisoprodol are often higher than expected even at the recommended dose, which may make safe use difficult.
  • The CHMP recommended suspension in all EU markets in November 2007; the European Commission's decision followed in February 2008.

Safety essentials

  • The EMA advised prescribers not to issue any new prescriptions for carisoprodol and to switch patients to an alternative treatment if necessary.
  • If you already take it, do not stop abruptly — ask your doctor about other treatment options.
  • Psychomotor impairment and intoxication are identified risks: do not drive or use machinery while taking it.
  • Abuse and addiction are identified risks: never take more than prescribed and never share it.

Source: EMA — Carisoprodol referral

How it works

Carisoprodol does not act directly on skeletal muscle. Instead, it works within the central nervous system, where it is thought to alter activity between neurons in the spinal cord and brain, producing a sedative effect and reducing the perception of muscle discomfort. In the body it is partly metabolised to meprobamate, a compound with sedative properties, which contributes to its effects and to its potential for dependence.

How it is taken

There is no current EU product information for carisoprodol to give dosing instructions from: the EMA recommended suspending all its marketing authorisations in the EU and told prescribers to switch patients to an alternative treatment if necessary. If you already take carisoprodol, do not stop abruptly — ask your doctor about other treatment options — and never take more than prescribed.

Carisoprodol side effects

Reported side effects:

  • Drowsiness and sleepiness
  • Dizziness or light-headedness
  • Headache
  • Nausea or upset stomach
  • Feeling unsteady or impaired coordination

Stop and seek medical help if you experience:

  • Allergic reactions such as rash, swelling of the face or throat, or difficulty breathing
  • Severe drowsiness, confusion or loss of consciousness, particularly if combined with alcohol or other sedatives
  • Seizures
  • Signs of dependence, withdrawal or misuse with prolonged use
  • A rare reaction shortly after the first dose involving extreme weakness, temporary loss of vision, confusion and agitation

Safety & who should not take it

  • EU status: the European Medicines Agency recommended in 2007 that all carisoprodol marketing authorisations in the EU be suspended, because of the risk of abuse and addiction, intoxication and impaired coordination, and advised prescribers to switch patients to alternative treatments.
  • Intended for short-term use only (usually no more than two to three weeks); it is not for long-term treatment.
  • May cause marked drowsiness and dizziness — do not drive or operate machinery until you know how it affects you.
  • Do not drink alcohol while taking carisoprodol, as this greatly increases sedation.
  • Avoid combining with other sedatives, sleeping tablets, opioids or central-nervous-system depressants unless a doctor advises.
  • Carisoprodol has a potential for dependence and misuse; take it only as prescribed and do not share it.
  • Tell your doctor about all your medical conditions and medicines, and if you are pregnant, planning pregnancy or breastfeeding.
  • Do not stop a long-running course abruptly, as withdrawal symptoms may occur; seek medical advice on stopping.

Storage

Store in the original packaging at room temperature, away from excess heat, moisture and direct light, out of the sight and reach of children. Do not use after the expiry date, and dispose of unused medicine safely through a pharmacy.

Frequently asked questions

What is carisoprodol's status in the EU?+

In November 2007 the EMA's scientific committee concluded that the benefits of carisoprodol medicines no longer outweigh their risks and recommended suspending all their marketing authorisations in the EU; the European Commission's decision followed in February 2008. Before that, carisoprodol was authorised in 12 European countries and available only on prescription.

Why was carisoprodol suspended in the EU?+

The EMA identified a risk of abuse and addiction, intoxication and psychomotor impairment (unusual thoughts and difficulty co-ordinating movements). It found that blood levels are often higher than expected even at the recommended dose, and that alternative medicines for lower back pain seem as effective with a better safety profile.

What are the side effects of carisoprodol?+

Drowsiness, dizziness and headache are commonly reported, and it can impair coordination. The EMA's review highlighted the more serious risks: abuse and addiction, intoxication and psychomotor impairment. Do not combine it with alcohol or other sedatives, and ask a doctor before stopping rather than stopping abruptly.

Can I take carisoprodol for long-term muscle pain?+

No. Carisoprodol is intended only for short-term use, generally no more than two to three weeks. For ongoing or chronic muscle problems, speak to your doctor about more suitable approaches.

Is it safe to drink alcohol while taking carisoprodol?+

No. Alcohol can greatly increase the sedative effects, leading to severe drowsiness, impaired coordination and breathing problems. Avoid alcohol entirely during treatment.

Can carisoprodol cause dependence?+

Yes, particularly with prolonged use or higher-than-prescribed doses, partly because it is metabolised to meprobamate. Take it only as prescribed, and ask your doctor before stopping a long course.

Important: This information is general and not a substitute for medical advice. Always read the patient information leaflet supplied with your medicine and consult a doctor or pharmacist before use — especially if you have existing health conditions or take other medication.

Sources

Carisoprodol health guides

Carisoprodol 500mg (Pain-O-Soma): uses, risks and the honest rules

Summary: Carisoprodol 500mg, sold as Pain-O-Soma 500, is a muscle relaxant for short courses of acute muscle pain. The EMA recommended suspending all EU carisoprodol authorisations in 2007 because of abuse, addiction and impairment risks. It causes drowsiness, must never be mixed with alcohol and carries genuine dependence potential. Use it only as a prescriber directs.

Read guide

Carisoprodol (Pain O Soma): A Short-Term Use Guide

Summary: Carisoprodol (Pain O Soma) is a muscle relaxant for short courses of acute muscle pain, used alongside rest and physiotherapy. It acts on the nervous system, so it commonly causes drowsiness and dizziness: don't drive, and never mix it with alcohol. It can be habit-forming, so use it only for the short period your doctor advises.

Read guide

Pain-O-Soma 350 vs 500: Understanding Carisoprodol Strengths

Summary: Pain-O-Soma 350 and 500 both contain carisoprodol, a muscle relaxant; the number is the strength in milligrams. The higher strength mainly brings more drowsiness and dizziness. Either is for short courses only, because carisoprodol can be habit-forming. Avoid alcohol, don't drive if drowsy, and let a doctor choose the lowest strength that helps.

Read guide

Pain-O-Soma for Muscle Pain: Short-Term Relief, Used Carefully

Summary: Pain-O-Soma is carisoprodol, a muscle relaxant for short-term relief of acute muscle strains and spasms, usually alongside rest and physiotherapy. It acts on the nervous system rather than the muscle. Courses are short, usually no more than a couple of weeks, because dependence and tolerance can develop. It causes drowsiness, so avoid alcohol and driving.

Read guide
Order on WhatsAppOrder on Telegram